Global Dermal Fillers and Botulinum Toxin Market Insights and Forecast to 2027

1 Study Coverage

• 1.1 Dermal Fillers and Botulinum Toxin Product Introduction
• 1.2 Market by Type
  • 1.2.1 Global Dermal Fillers and Botulinum Toxin Market Size Growth Rate by Type
  • 1.4.2 Dermal Fillers
  • 1.4.3 Botulinum Toxin
• 1.3 Market by Application
  • 1.3.1 Global Dermal Fillers and Botulinum Toxin Market Size Growth Rate by Application
  • 1.3.2 Medical
  • 1.3.3 Cosmetic
• 1.4 Study Objectives
• 1.5 Years Considered

2 Executive Summary

• 2.1 Global Dermal Fillers and Botulinum Toxin Sales Estimates and Forecasts 2016-2027
• 2.2 Global Dermal Fillers and Botulinum Toxin Revenue Estimates and Forecasts 2016-2027
• 2.3 Global Dermal Fillers and Botulinum Toxin Revenue by Region: 2016 VS 2021 VS 2027
• 2.4 Global Top Dermal Fillers and Botulinum Toxin Regions by Sales
  • 2.4.1 Global Top Dermal Fillers and Botulinum Toxin Regions by Sales (2016-2021)
  • 2.4.2 Global Top Dermal Fillers and Botulinum Toxin Regions by Sales (2022-2027)
• 2.5 Global Top Dermal Fillers and Botulinum Toxin Regions by Revenue
  • 2.5.1 Global Top Dermal Fillers and Botulinum Toxin Regions by Revenue (2016-2021)
  • 2.5.2 Global Top Dermal Fillers and Botulinum Toxin Regions by Revenue (2022-2027)
• 2.6 North America
• 2.7 Europe
• 2.8 Asia-Pacific
• 2.9 Latin America
• 2.10 Middle East & Africa

3 Competition by Manufacturers

• 3.1 Global Dermal Fillers and Botulinum Toxin Sales by Manufacturers
  • 3.1.1 Global Top Dermal Fillers and Botulinum Toxin Manufacturers by Sales (2016-2021)
  • 3.1.2 Global Top Dermal Fillers and Botulinum Toxin Manufacturers Market Share by Sales (2016-2021)
  • 3.1.3 Global Top 10 and Top 5 Companies by Dermal Fillers and Botulinum Toxin Sales in 2020
• 3.2 Global Dermal Fillers and Botulinum Toxin Revenue by Manufacturers
  • 3.2.1 Global Top Dermal Fillers and Botulinum Toxin Manufacturers by Revenue (2016-2021)
  • 3.2.2 Global Top Dermal Fillers and Botulinum Toxin Manufacturers Market Share by Revenue (2016-2021)
  • 3.2.3 Global Top 10 and Top 5 Companies by Dermal Fillers and Botulinum Toxin Revenue in 2020
• 3.3 Global Dermal Fillers and Botulinum Toxin Sales Price by Manufacturers
• 3.4 Analysis of Competitive Landscape
  • 3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Dermal Fillers and Botulinum Toxin Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
  • 3.4.3 Global Dermal Fillers and Botulinum Toxin Manufacturers Geographical Distribution
• 3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

• 4.1 Global Dermal Fillers and Botulinum Toxin Sales by Type
  • 4.1.1 Global Dermal Fillers and Botulinum Toxin Historical Sales by Type (2016-2021)
  • 4.1.2 Global Dermal Fillers and Botulinum Toxin Forecasted Sales by Type (2022-2027)
  • 4.1.3 Global Dermal Fillers and Botulinum Toxin Sales Market Share by Type (2016-2027)
• 4.2 Global Dermal Fillers and Botulinum Toxin Revenue by Type
  • 4.2.1 Global Dermal Fillers and Botulinum Toxin Historical Revenue by Type (2016-2021)
  • 4.2.2 Global Dermal Fillers and Botulinum Toxin Forecasted Revenue by Type (2022-2027)
  • 4.2.3 Global Dermal Fillers and Botulinum Toxin Revenue Market Share by Type (2016-2027)
• 4.3 Global Dermal Fillers and Botulinum Toxin Price by Type
  • 4.3.1 Global Dermal Fillers and Botulinum Toxin Price by Type (2016-2021)
  • 4.3.2 Global Dermal Fillers and Botulinum Toxin Price Forecast by Type (2022-2027)

5 Market Size by Application

• 5.1 Global Dermal Fillers and Botulinum Toxin Sales by Application
  • 5.1.1 Global Dermal Fillers and Botulinum Toxin Historical Sales by Application (2016-2021)
  • 5.1.2 Global Dermal Fillers and Botulinum Toxin Forecasted Sales by Application (2022-2027)
  • 5.1.3 Global Dermal Fillers and Botulinum Toxin Sales Market Share by Application (2016-2027)
• 5.2 Global Dermal Fillers and Botulinum Toxin Revenue by Application
  • 5.2.1 Global Dermal Fillers and Botulinum Toxin Historical Revenue by Application (2016-2021)
  • 5.2.2 Global Dermal Fillers and Botulinum Toxin Forecasted Revenue by Application (2022-2027)
  • 5.2.3 Global Dermal Fillers and Botulinum Toxin Revenue Market Share by Application (2016-2027)
• 5.3 Global Dermal Fillers and Botulinum Toxin Price by Application
  • 5.3.1 Global Dermal Fillers and Botulinum Toxin Price by Application (2016-2021)
  • 5.3.2 Global Dermal Fillers and Botulinum Toxin Price Forecast by Application (2022-2027)

6 North America

• 6.1 North America Dermal Fillers and Botulinum Toxin Market Size by Type
  • 6.1.1 North America Dermal Fillers and Botulinum Toxin Sales by Type (2016-2027)
  • 6.1.2 North America Dermal Fillers and Botulinum Toxin Revenue by Type (2016-2027)
• 6.2 North America Dermal Fillers and Botulinum Toxin Market Size by Application
  • 6.2.1 North America Dermal Fillers and Botulinum Toxin Sales by Application (2016-2027)
  • 6.2.2 North America Dermal Fillers and Botulinum Toxin Revenue by Application (2016-2027)
• 6.3 North America Dermal Fillers and Botulinum Toxin Market Size by Country
  • 6.3.1 North America Dermal Fillers and Botulinum Toxin Sales by Country (2016-2027)
  • 6.3.2 North America Dermal Fillers and Botulinum Toxin Revenue by Country (2016-2027)
  • 6.3.3 U.S.
  • 6.3.4 Canada

7 Europe

• 7.1 Europe Dermal Fillers and Botulinum Toxin Market Size by Type
  • 7.1.1 Europe Dermal Fillers and Botulinum Toxin Sales by Type (2017-2027)
  • 7.1.2 Europe Dermal Fillers and Botulinum Toxin Revenue by Type (2017-2027)
• 7.2 Europe Dermal Fillers and Botulinum Toxin Market Size by Application
  • 7.2.1 Europe Dermal Fillers and Botulinum Toxin Sales by Application (2017-2027)
  • 7.2.2 Europe Dermal Fillers and Botulinum Toxin Revenue by Application (2017-2027)
• 7.3 Europe Dermal Fillers and Botulinum Toxin Market Size by Country
  • 7.3.1 Europe Dermal Fillers and Botulinum Toxin Sales by Country (2017-2027)
  • 7.3.2 Europe Dermal Fillers and Botulinum Toxin Revenue by Country (2017-2027)
  • 7.3.3 Germany
  • 7.3.4 France
  • 7.3.5 U.K.
  • 7.3.6 Italy
  • 7.3.7 Russia

8 Asia Pacific

• 8.1 Asia Pacific Dermal Fillers and Botulinum Toxin Market Size by Type
  • 8.1.1 Asia Pacific Dermal Fillers and Botulinum Toxin Sales by Type (2018-2027)
  • 8.1.2 Asia Pacific Dermal Fillers and Botulinum Toxin Revenue by Type (2018-2027)
• 8.2 Asia Pacific Dermal Fillers and Botulinum Toxin Market Size by Application
  • 8.2.1 Asia Pacific Dermal Fillers and Botulinum Toxin Sales by Application (2018-2027)
  • 8.2.2 Asia Pacific Dermal Fillers and Botulinum Toxin Revenue by Application (2018-2027)
• 8.3 Asia Pacific Dermal Fillers and Botulinum Toxin Market Size by Region
  • 8.3.1 Asia Pacific Dermal Fillers and Botulinum Toxin Sales by Region (2018-2027)
  • 8.3.2 Asia Pacific Dermal Fillers and Botulinum Toxin Revenue by Region (2018-2027)
  • 8.3.3 China
  • 8.3.4 Japan
  • 8.3.5 South Korea
  • 8.3.6 India
  • 8.3.7 Australia
  • 8.3.8 Taiwan
  • 8.3.9 Indonesia
  • 8.3.10 Thailand
  • 8.3.11 Malaysia
  • 8.3.12 Philippines

9 Latin America

• 9.1 Latin America Dermal Fillers and Botulinum Toxin Market Size by Type
  • 9.1.1 Latin America Dermal Fillers and Botulinum Toxin Sales by Type (2019-2027)
  • 9.1.2 Latin America Dermal Fillers and Botulinum Toxin Revenue by Type (2019-2027)
• 9.2 Latin America Dermal Fillers and Botulinum Toxin Market Size by Application
  • 9.2.1 Latin America Dermal Fillers and Botulinum Toxin Sales by Application (2019-2027)
  • 9.2.2 Latin America Dermal Fillers and Botulinum Toxin Revenue by Application (2019-2027)
• 9.3 Latin America Dermal Fillers and Botulinum Toxin Market Size by Country
  • 9.3.1 Latin America Dermal Fillers and Botulinum Toxin Sales by Country (2019-2027)
  • 9.3.2 Latin America Dermal Fillers and Botulinum Toxin Revenue by Country (2019-2027)
  • 9.3.3 Mexico
  • 9.3.4 Brazil
  • 9.3.5 Argentina

6 Middle East and Africa

• 6.1 Middle East and Africa Dermal Fillers and Botulinum Toxin Market Size by Type
  • 6.1.1 Middle East and Africa Dermal Fillers and Botulinum Toxin Sales by Type (2016-2027)
  • 6.1.2 Middle East and Africa Dermal Fillers and Botulinum Toxin Revenue by Type (2016-2027)
• 6.2 Middle East and Africa Dermal Fillers and Botulinum Toxin Market Size by Application
  • 6.2.1 Middle East and Africa Dermal Fillers and Botulinum Toxin Sales by Application (2016-2027)
  • 6.2.2 Middle East and Africa Dermal Fillers and Botulinum Toxin Revenue by Application (2016-2027)
• 6.3 Middle East and Africa Dermal Fillers and Botulinum Toxin Market Size by Country
  • 6.3.1 Middle East and Africa Dermal Fillers and Botulinum Toxin Sales by Country (2016-2027)
  • 6.3.2 Middle East and Africa Dermal Fillers and Botulinum Toxin Revenue by Country (2016-2027)
  • 6.3.3 Turkey
  • 6.3.4 Saudi Arabia
  • 6.3.5 U.A.E

11 Company Profiles

• 11.1 Allergan
  • 11.1.1 Allergan Corporation Information
  • 11.1.2 Allergan Overview
  • 11.1.3 Allergan Dermal Fillers and Botulinum Toxin Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.1.4 Allergan Dermal Fillers and Botulinum Toxin Product Description
  • 11.1.5 Allergan Related Developments
• 11.2 Galderma
  • 11.2.1 Galderma Corporation Information
  • 11.2.2 Galderma Overview
  • 11.2.3 Galderma Dermal Fillers and Botulinum Toxin Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.2.4 Galderma Dermal Fillers and Botulinum Toxin Product Description
  • 11.2.5 Galderma Related Developments
• 11.3 LG Life Science
  • 11.3.1 LG Life Science Corporation Information
  • 11.3.2 LG Life Science Overview
  • 11.3.3 LG Life Science Dermal Fillers and Botulinum Toxin Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.3.4 LG Life Science Dermal Fillers and Botulinum Toxin Product Description
  • 11.3.5 LG Life Science Related Developments
• 11.4 Merz
  • 11.4.1 Merz Corporation Information
  • 11.4.2 Merz Overview
  • 11.4.3 Merz Dermal Fillers and Botulinum Toxin Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.4.4 Merz Dermal Fillers and Botulinum Toxin Product Description
  • 11.4.5 Merz Related Developments
• 11.5 Medytox
  • 11.5.1 Medytox Corporation Information
  • 11.5.2 Medytox Overview
  • 11.5.3 Medytox Dermal Fillers and Botulinum Toxin Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.5.4 Medytox Dermal Fillers and Botulinum Toxin Product Description
  • 11.5.5 Medytox Related Developments
• 11.6 Bloomage
  • 11.6.1 Bloomage Corporation Information
  • 11.6.2 Bloomage Overview
  • 11.6.3 Bloomage Dermal Fillers and Botulinum Toxin Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.6.4 Bloomage Dermal Fillers and Botulinum Toxin Product Description
  • 11.6.5 Bloomage Related Developments
• 11.7 Bohus BioTech
  • 11.7.1 Bohus BioTech Corporation Information
  • 11.7.2 Bohus BioTech Overview
  • 11.7.3 Bohus BioTech Dermal Fillers and Botulinum Toxin Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.7.4 Bohus BioTech Dermal Fillers and Botulinum Toxin Product Description
  • 11.7.5 Bohus BioTech Related Developments
• 11.8 Sinclair Pharma
  • 11.8.1 Sinclair Pharma Corporation Information
  • 11.8.2 Sinclair Pharma Overview
  • 11.8.3 Sinclair Pharma Dermal Fillers and Botulinum Toxin Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.8.4 Sinclair Pharma Dermal Fillers and Botulinum Toxin Product Description
  • 11.8.5 Sinclair Pharma Related Developments
• 11.9 IMEIK
  • 11.9.1 IMEIK Corporation Information
  • 11.9.2 IMEIK Overview
  • 11.9.3 IMEIK Dermal Fillers and Botulinum Toxin Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.9.4 IMEIK Dermal Fillers and Botulinum Toxin Product Description
  • 11.9.5 IMEIK Related Developments
• 11.10 Suneva Medical
  • 11.10.1 Suneva Medical Corporation Information
  • 11.10.2 Suneva Medical Overview
  • 11.10.3 Suneva Medical Dermal Fillers and Botulinum Toxin Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.10.4 Suneva Medical Dermal Fillers and Botulinum Toxin Product Description
  • 11.10.5 Suneva Medical Related Developments
• 11.1 Allergan
  • 11.1.1 Allergan Corporation Information
  • 11.1.2 Allergan Overview
  • 11.1.3 Allergan Dermal Fillers and Botulinum Toxin Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.1.4 Allergan Dermal Fillers and Botulinum Toxin Product Description
  • 11.1.5 Allergan Related Developments
• 11.12 Luminera
  • 11.12.1 Luminera Corporation Information
  • 11.12.2 Luminera Overview
  • 11.12.3 Luminera Dermal Fillers and Botulinum Toxin Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.12.4 Luminera Product Description
  • 11.12.5 Luminera Related Developments
• 11.13 SciVision Biotech
  • 11.13.1 SciVision Biotech Corporation Information
  • 11.13.2 SciVision Biotech Overview
  • 11.13.3 SciVision Biotech Dermal Fillers and Botulinum Toxin Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.13.4 SciVision Biotech Product Description
  • 11.13.5 SciVision Biotech Related Developments
• 11.14 Haohai Bio
  • 11.14.1 Haohai Bio Corporation Information
  • 11.14.2 Haohai Bio Overview
  • 11.14.3 Haohai Bio Dermal Fillers and Botulinum Toxin Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.14.4 Haohai Bio Product Description
  • 11.14.5 Haohai Bio Related Developments
• 11.15 Ipsen
  • 11.15.1 Ipsen Corporation Information
  • 11.15.2 Ipsen Overview
  • 11.15.3 Ipsen Dermal Fillers and Botulinum Toxin Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.15.4 Ipsen Product Description
  • 11.15.5 Ipsen Related Developments
• 11.16 LIBP
  • 11.16.1 LIBP Corporation Information
  • 11.16.2 LIBP Overview
  • 11.16.3 LIBP Dermal Fillers and Botulinum Toxin Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.16.4 LIBP Product Description
  • 11.16.5 LIBP Related Developments
• 11.17 US World Meds
  • 11.17.1 US World Meds Corporation Information
  • 11.17.2 US World Meds Overview
  • 11.17.3 US World Meds Dermal Fillers and Botulinum Toxin Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.17.4 US World Meds Product Description
  • 11.17.5 US World Meds Related Developments
• 11.18 Hugel
  • 11.18.1 Hugel Corporation Information
  • 11.18.2 Hugel Overview
  • 11.18.3 Hugel Dermal Fillers and Botulinum Toxin Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.18.4 Hugel Product Description
  • 11.18.5 Hugel Related Developments
• 11.19 Daewoong
  • 11.19.1 Daewoong Corporation Information
  • 11.19.2 Daewoong Overview
  • 11.19.3 Daewoong Dermal Fillers and Botulinum Toxin Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.19.4 Daewoong Product Description
  • 11.19.5 Daewoong Related Developments

12 Value Chain and Sales Channels Analysis

• 12.1 Dermal Fillers and Botulinum Toxin Value Chain Analysis
• 12.2 Dermal Fillers and Botulinum Toxin Key Raw Materials
  • 12.2.1 Key Raw Materials
  • 12.2.2 Raw Materials Key Suppliers
• 12.3 Dermal Fillers and Botulinum Toxin Production Mode & Process
• 12.4 Dermal Fillers and Botulinum Toxin Sales and Marketing
  • 12.4.1 Dermal Fillers and Botulinum Toxin Sales Channels
  • 12.4.2 Dermal Fillers and Botulinum Toxin Distributors
• 12.5 Dermal Fillers and Botulinum Toxin Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis

• 13.1 Dermal Fillers and Botulinum Toxin Industry Trends
• 13.2 Dermal Fillers and Botulinum Toxin Market Drivers
• 13.3 Dermal Fillers and Botulinum Toxin Market Challenges
• 13.4 Dermal Fillers and Botulinum Toxin Market Restraints

14 Key Findings in The Global Dermal Fillers and Botulinum Toxin Study

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Author Details